|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gynecologic cancer
Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
So Hyun Nam, Shin-Wha Lee, Young-Jae Lee, Yong Man Kim
Cancer Res Treat.
2023;55(4):1346-1354. Published online May 15, 2023 DOI:
https://doi.org/10.4143/crt.2022.1436
Web of Science 1
Crossref 1
Pediatric cancer
Gonadal Function in Female Adolescent and Young Adult Survivors of Childhood Cancer
Hye Young Jin, Jun Ah Lee, Meerim Park, Hyeon Jin Park
Cancer Res Treat.
2023;55(3):992-1000. Published online January 31, 2023 DOI:
https://doi.org/10.4143/crt.2022.1518
Gynecologic cancer
Effect of
BRCA1/2
Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed
Ovarian
Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.
2023;55(1):245-257. Published online July 19, 2022 DOI:
https://doi.org/10.4143/crt.2022.232
Identification of Patients with Recurrent Epithelial
Ovarian
Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.
2022;54(4):1219-1229. Published online November 17, 2021 DOI:
https://doi.org/10.4143/crt.2021.1010
Web of Science 1
Crossref 1
Gynecologic Cancer
Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial
Ovarian
Cancer Cells
Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No
Cancer Res Treat.
2021;53(3):819-828. Published online December 16, 2020 DOI:
https://doi.org/10.4143/crt.2020.1013
Web of Science 4
Crossref 3
Gynecologic cancer
Second Primary
Ovarian
Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim
Cancer Res Treat.
2021;53(2):541-548. Published online November 18, 2020 DOI:
https://doi.org/10.4143/crt.2020.1001
Crossref 2
Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with
Ovarian
Cancer with
BRCA1
or
BRCA2
Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.
2021;53(1):207-211. Published online August 11, 2020 DOI:
https://doi.org/10.4143/crt.2020.364
Web of Science 7
Crossref 6
Germline and Somatic
BRCA1/2
Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal,
Ovarian
, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.
2020;52(4):1229-1241. Published online July 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.557
Web of Science 10
Crossref 3
Evaluation of Circulating Tumor DNA in Patients with
Ovarian
Cancer Harboring Somatic
PIK3CA
or
KRAS
Mutations
Aiko Ogasawara, Taro Hihara, Daisuke Shintani, Akira Yabuno, Yuji Ikeda, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa
Cancer Res Treat.
2020;52(4):1219-1228. Published online May 6, 2020 DOI:
https://doi.org/10.4143/crt.2019.688
Web of Science 12
Crossref 4
Early Assessment of Response to Neoadjuvant Chemotherapy with
18
F-FDG-PET/CT in Patients with Advanced-Stage
Ovarian
Cancer
Young Shin Chung, Hyun-Soo Kim, Jung-Yun Lee, Won Jun Kang, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
Cancer Res Treat.
2020;52(4):1211-1218. Published online April 28, 2020 DOI:
https://doi.org/10.4143/crt.2019.506
Web of Science 6
Crossref 2
G Protein–Coupled Receptor 30 Mediates the Anticancer Effects Induced by Eicosapentaenoic Acid in
Ovarian
Cancer Cells
Yue Zhao, Meng-Fei Zhao, Mei-Lin Yang, Tian-Yu Wu, Cong-Jian Xu, Jing-Mei Wang, Chao-Jun Li, Xi Li
Cancer Res Treat.
2020;52(3):815-829. Published online March 5, 2020 DOI:
https://doi.org/10.4143/crt.2019.380
Web of Science 5
Crossref 7
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of
Ovarian
Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang, Na Li, Yu-Lan Cui
Cancer Res Treat.
2020;52(3):798-814. Published online March 3, 2020 DOI:
https://doi.org/10.4143/crt.2019.498
Web of Science 30
Crossref 29
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in
Ovarian
Cancer
Mi-Ryung Han, Sug Hyung Lee, Jung Yoon Park, Hyosun Hong, Jung Yoon Ho, Soo Young Hur, Youn Jin Choi
Cancer Res Treat.
2020;52(3):779-788. Published online February 28, 2020 DOI:
https://doi.org/10.4143/crt.2019.700
Web of Science 22
Crossref 23
Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat.
2020;52(3):697-713. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.559
Web of Science 26
Crossref 25
Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of
Ovarian
Cancer Patients
Min Ae Cho, Soo Young Jeong, Insuk Sohn, Myeong-Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Chel Hun Choi
Cancer Res Treat.
2020;52(2):645-654. Published online January 16, 2020 DOI:
https://doi.org/10.4143/crt.2019.509
Web of Science 13
Crossref 12
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in
Ovarian
High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Tae-Heon Kim, Haeyoun Kang, Hee Jung An
Cancer Res Treat.
2020;52(2):634-644. Published online January 6, 2020 DOI:
https://doi.org/10.4143/crt.2019.207
Web of Science 13
Crossref 13
Clinical Characteristics of Clear Cell
Ovarian
Cancer: A Retrospective Multicenter Experience of 308 Patients in South Korea
Hee Yeon Lee, Ji Hyung Hong, Jae Ho Byun, Hee-Jun Kim, Sun Kyung Baek, Jin Young Kim, Ki Hyang Kim, Jina Yun, Jung A Kim, Kwonoh Park, Hyo Jin Lee, Jung Lim Lee, Young-Woong Won, Il Hwan Kim, Woo Kyun Bae, Kyong Hwa Park, Der-Sheng Sun, Suee Lee, Min-Young Lee, Guk Jin Lee, Sook Hee Hong, Yun Hwa Jung, Ho Jung An
Cancer Res Treat.
2020;52(1):277-283. Published online July 12, 2019 DOI:
https://doi.org/10.4143/crt.2019.292
Web of Science 19
Crossref 14
Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial
Ovarian
Cancer
Se Ik Kim, Minsun Song, Suhyun Hwangbo, Sungyoung Lee, Untack Cho, Ju-Hyun Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Dae-Shik Suh, Taesung Park, Yong-Sang Song
Cancer Res Treat.
2019;51(3):1144-1155. Published online November 20, 2018 DOI:
https://doi.org/10.4143/crt.2018.508
Web of Science 16
Crossref 15
Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of
Ovarian
Cancer
Lan Ying Li, Hee Jung Kim, Sun Ae Park, So Hyun Lee, Lee Kyung Kim, Jung Yun Lee, Sunghoon Kim, Young Tae Kim, Sang Wun Kim, Eun Ji Nam
Cancer Res Treat.
2019;51(3):1117-1127. Published online November 6, 2018 DOI:
https://doi.org/10.4143/crt.2018.405
Web of Science 17
Crossref 14
Clinical and Genetic Characteristics of
BRCA1/2
Mutation in Korean
Ovarian
Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Res Treat.
2019;51(3):941-950. Published online October 8, 2018 DOI:
https://doi.org/10.4143/crt.2018.312
Web of Science 8
Crossref 8
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Web of Science 10
Crossref 9
Development and Validation of
Ovarian
Symptom Index-18 and Neurotoxicity-4 for Korean Patients with
Ovarian
, Fallopian Tube, or Primary Peritoneal Cancer
Maria Lee, Yumi Lee, Kidong Kim, Eun Young Park, Myong Cheol Lim, Jung-Sup Kim, Hee Seung Kim, Yong-Beom Kim, Yong-Man Kim, Jungnam Joo, Sang Yoon Park, Chel Hun Choi, Jae-Hoon Kim
Cancer Res Treat.
2019;51(1):112-118. Published online March 7, 2018 DOI:
https://doi.org/10.4143/crt.2017.361
Web of Science 4
Crossref 4
Comparison of Clinical Features and Outcomes in Epithelial
Ovarian
Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
Kyung Jin Eoh, Young Shin Chung, So Hyun Lee, Sun-Ae Park, Hee Jung Kim, Wookyeom Yang, In Ok Lee, Jung-Yun Lee, Hanbyoul Cho, Doo Byung Chay, Sunghoon Kim, Sang Wun Kim, Jae-Hoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2018;50(3):956-963. Published online October 17, 2017 DOI:
https://doi.org/10.4143/crt.2017.181
Web of Science 16
Crossref 16
Detection of Germline Mutations in Patients with Epithelial
Ovarian
Cancer Using Multi-gene Panels: Beyond
BRCA1/2
Kyung Jin Eoh, Ji Eun Kim, Hyung Seok Park, Seung-Tae Lee, Ji Soo Park, Jung Woo Han, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Jae Hoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2018;50(3):917-925. Published online September 27, 2017 DOI:
https://doi.org/10.4143/crt.2017.220
Web of Science 31
Crossref 28
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for
Ovarian
Cancer
Jun Hwa Lee, Yun Hwan Kim, Kyung-Hee Kim, Jae Youl Cho, Sang Myung Woo, Byong Chul Yoo, Seung Cheol Kim
Cancer Res Treat.
2018;50(3):883-893. Published online September 18, 2017 DOI:
https://doi.org/10.4143/crt.2017.275
Web of Science 9
Crossref 8
Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial
Ovarian
Cancer
E Sun Paik, Hyun Jin Choi, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
Cancer Res Treat.
2018;50(2):461-473. Published online May 22, 2017 DOI:
https://doi.org/10.4143/crt.2017.104
Web of Science 5
Crossref 1
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for
Ovarian
Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
Shin-Wha Lee, Yong-Man Kim, Chi Heum Cho, Young Tae Kim, Seok Mo Kim, Soo Young Hur, Jae-Hoon Kim, Byoung-Gie Kim, Seung-Cheol Kim, Hee-Sug Ryu, Soon Beom Kang
Cancer Res Treat.
2018;50(1):195-203. Published online March 21, 2017 DOI:
https://doi.org/10.4143/crt.2016.376
Web of Science 53
Crossref 50
Patient-Derived Xenograft Models of Epithelial
Ovarian
Cancer for Preclinical Studies
Eun Jin Heo, Young Jae Cho, William Chi Cho, Ji Eun Hong, Hye-Kyung Jeon, Doo-Yi Oh, Yoon-La Choi, Sang Yong Song, Jung-Joo Choi, Duk-Soo Bae, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Woong-Yang Park, Byoung-Gie Kim, Jeong-Won Lee
Cancer Res Treat.
2017;49(4):915-926. Published online January 4, 2017 DOI:
https://doi.org/10.4143/crt.2016.322
Web of Science 52
Crossref 48
Long Non-coding RNA
HOXA11
Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous
Ovarian
Cancer
Ga Won Yim, Hee Jung Kim, Lee Kyung Kim, Sang Wun Kim, Sunghoon Kim, Eun Ji Nam, Young Tae Kim
Cancer Res Treat.
2017;49(3):656-668. Published online October 11, 2016 DOI:
https://doi.org/10.4143/crt.2016.263
Web of Science 35
Crossref 28
Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial
Ovarian
Cancer
E Sun Paik, Insuk Sohn, Sun-Young Baek, Minhee Shim, Hyun Jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Yoo-Young Lee, Duk-Soo Bae
Cancer Res Treat.
2017;49(3):635-642. Published online September 27, 2016 DOI:
https://doi.org/10.4143/crt.2016.282
Web of Science 10
Crossref 9
1
2
Journal Impact Factor 4.6